Hiroyuki Seimiya Selected Research

Hiroyuki Seimiya Research Topics

Disease

46	Neoplasms (Cancer) 05/2024 - 04/2002
12	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 06/2016
7	Carcinogenesis 11/2023 - 07/2002
5	Glioma (Gliomas) 05/2019 - 08/2009
4	Stomach Neoplasms (Stomach Cancer) 05/2024 - 11/2019
4	AIDS-Related Complex (ARC) 01/2020 - 03/2004
4	Arthrogryposis renal dysfunction cholestasis syndrome 01/2020 - 03/2004
4	Prostatic Neoplasms (Prostate Cancer) 09/2014 - 11/2010
3	Residual Neoplasm 05/2024 - 11/2019
3	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2024 - 01/2017
2	Colonic Neoplasms (Colon Cancer) 01/2021 - 01/2020
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2018 - 10/2008
2	Adenocarcinoma of Lung 04/2010 - 10/2008
2	Lung Neoplasms (Lung Cancer) 10/2008 - 09/2004
1	Melanoma (Melanoma, Malignant) 01/2024
1	Carcinoma (Carcinomatosis) 11/2023
1	Breast Neoplasms (Breast Cancer) 11/2023
1	Starvation 11/2023
1	TDP-43 Proteinopathies 01/2021
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 09/2020
1	Circulating Neoplastic Cells 02/2020
1	Neutropenia 01/2020
1	Disease Progression 01/2020
1	Hypersensitivity (Allergy) 01/2020
1	Type 2 Diabetes Mellitus (MODY) 11/2018
1	Non-Muscle Invasive Bladder Neoplasms 01/2017
1	Glioblastoma (Glioblastoma Multiforme) 01/2017

Drug/Important Bio-Agent (IBA)

20	TankyrasesIBA 01/2024 - 04/2002
9	Proteins (Proteins, Gene)FDA Link 01/2024 - 06/2007
9	LigandsIBA 11/2020 - 03/2012
9	Telomerase (Telomerase Reverse Transcriptase)IBA 09/2020 - 07/2002
6	EnzymesIBA 01/2024 - 08/2009
6	CateninsIBA 01/2024 - 01/2017
5	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 06/2007
4	RNA (Ribonucleic Acid)IBA 05/2024 - 02/2015
4	telomestatinIBA 10/2021 - 03/2012
4	Biomarkers (Surrogate Marker)IBA 12/2018 - 04/2010
3	Fluorouracil (Carac)FDA LinkGeneric 05/2024 - 03/2020
3	Transforming Growth Factors (Transforming Growth Factor)IBA 05/2024 - 01/2017
3	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 09/2020 - 01/2007
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2020 - 11/2019
3	MST 312IBA 10/2018 - 07/2002
3	ATP Citrate (pro-S)-Lyase (Citrate Synthase, ATP)IBA 07/2014 - 10/2008
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 05/2024 - 01/2020
2	Histones (Histone)IBA 04/2024 - 11/2023
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 06/2016
2	regorafenibIBA 02/2020 - 06/2016
2	Cadherins (E-Cadherin)IBA 01/2017 - 08/2013
2	Phosphotransferases (Kinase)IBA 06/2016 - 10/2008
2	Fatty Acids (Saturated Fatty Acids)IBA 07/2014 - 08/2009
2	Hormones (Hormone)IBA 07/2012 - 11/2010
2	Adenosine Diphosphate (ADP)IBA 03/2004 - 04/2002
1	OTX015IBA 04/2024
1	Aldehyde Dehydrogenase 1 FamilyIBA 04/2024
1	Immune Checkpoint InhibitorsIBA 01/2024
1	Interleukin-4 (Interleukin 4)IBA 01/2024
1	Essential Amino AcidsIBA 01/2024
1	AntibodiesIBA 01/2024
1	L-Amino Acid OxidaseIBA 01/2024
1	Amino Acids FDA Link 01/2024
1	B7-H1 AntigenIBA 01/2024
1	Mechanistic Target of Rapamycin Complex 1IBA 11/2023
1	Glutamine (L-Glutamine)FDA Link 11/2023
1	OxazolesIBA 10/2021
1	lamellarin 14IBA 05/2021
1	Interferon-gamma (Interferon, gamma)IBA 02/2021
1	RNA Splicing FactorsIBA 02/2021
1	OligonucleotidesIBA 02/2021
1	Interleukin-8 (Interleukin 8)IBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	Alkenes (Olefins)IBA 01/2021
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2021
1	Untranslated RNA (Noncoding RNA)IBA 01/2021
1	RamucirumabIBA 01/2021
1	AzidesIBA 11/2020
1	artemisinin (artemisinine)IBA 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	trifluridine tipiracil drug combinationIBA 01/2020
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2020
1	ErbB Receptors (EGF Receptor)IBA 11/2019
1	Hypoglycemic Agents (Hypoglycemics)IBA 05/2019
1	TCF Transcription FactorsIBA 12/2018
1	Peptide Hydrolases (Proteases)FDA Link 11/2018
1	CalpainIBA 11/2018
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 10/2018
1	Lamin Type A (Lamin A)IBA 10/2018
1	Carrier Proteins (Binding Protein)IBA 01/2017
1	Alkylating AgentsIBA 01/2017

Therapy/Procedure

19	Therapeutics 04/2024 - 01/2005
2	Drug Therapy (Chemotherapy) 05/2024 - 04/2024
2	Aftercare (After-Treatment) 01/2024 - 11/2019
1	Neoadjuvant Therapy 04/2024
1	Treatment Delay 01/2020
1	Precision Medicine 05/2019
1	Oral Administration 12/2018